원저

갑상선 수질암의 술 후 경과에 있어서 Calcitonin의 유용성

문효성1, 김주연1, 이강대1,*
Hyo Sung Moon1, Ju Youn Kim1, Kang Dae Lee1,*
Author Information & Copyright
1고신대학교 의과대학 이비인후과학교실
1Department of Otolaryngology, Head and Neck Surgery, College of Medicine, Kosin University, Busan, Korea
*교신저자: 이강대, 602-702 부산광역시 서구 암남동 34 고신대학교 의과대학 이비인후과학교실 전화: (051) 990-6248·전송: (051) 245-8539 E-mail: kdlee@ns.kosinmed.or.kr

© Copyright 2002 The Busan, Ulsan, Gyeoungnam Branch of Korean Society of Otolaryngology-Head and Neck Surgery. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Oct 29, 2002; Accepted: Nov 08, 2002

Published Online: May 31, 2020

ABSTRACT

Calcitonin is secreted by thyroid C cell and medullary cancer cell. For the diagnosis of tumor recurrence in MTC patients, the postoperative calcitonin determination is of central importance. CT value decreasing into the normal range are regarded as evidence of complete tumor extirpatiojn, also called biochemical cure. However, there is persistent hypercalcitoninemia which means the presence of metastatic foci in the body after resection of medullary thyroid carcinoma. This study will examines the clinical availibility of level of calcitonin after surgery of medullary thyroid carcinoma. (J Clinical Otolaryngol 2002;13:199–203)

Keywords: 갑상선 수질암; 칼시토닌
Keywords: Medullary thyroid carcinoma; Calcitonin